{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:21:25Z","timestamp":1783124485257,"version":"3.54.6"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation (FAPESP)","doi-asserted-by":"publisher","award":["2011\/19670-0"],"award-info":[{"award-number":["2011\/19670-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation (FAPESP)","doi-asserted-by":"publisher","award":["2013\/08216-2"],"award-info":[{"award-number":["2013\/08216-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of S\u00e3o Paulo NAP-DIN","award":["11.1.21625.01.0"],"award-info":[{"award-number":["11.1.21625.01.0"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.phrs.2016.02.004","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T14:54:22Z","timestamp":1455375262000},"page":"58-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["C5a and pain development: An old molecule, a new target"],"prefix":"10.1016","volume":"112","author":[{"given":"Andreza U.","family":"Quadros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1084-0065","authenticated-orcid":false,"given":"Thiago M.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.02.004_bib0005","first-page":"2","article-title":"Pain clinical updates","volume":"11","author":"Harstall","year":"2003","journal-title":"IASP"},{"issue":"7","key":"10.1016\/j.phrs.2016.02.004_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn2533","article-title":"Pathological and protective roles of glia in chronic pain","volume":"10","author":"Milligan","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.phrs.2016.02.004_bib0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd2335","article-title":"Stimulating the development of mechanism-based, individualized pain therapies","volume":"6","author":"Woodcock","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gtc.2009.03.006","article-title":"Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs","volume":"38","author":"Scheiman","year":"2009","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"10","key":"10.1016\/j.phrs.2016.02.004_bib0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1586\/14737175.6.10.1423","article-title":"Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain","volume":"6","author":"Wallace","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.phrs.2016.02.004_bib0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system Part I\u2014molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4049\/jimmunol.120.3.850","article-title":"Leukocyte complement: neoantigens of the membrane attack complex on the surface of human leukocytes prepared from defibrinated blood","volume":"120","author":"Sundsmo","year":"1978","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0045","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1172\/JCI112249","article-title":"Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement","volume":"76","author":"Ezekowitz","year":"1985","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/intimm\/3.4.293","article-title":"Murine polymorphonuclear leukocytes synthesize and secrete the third component and factor B of complement","volume":"3","author":"Okuda","year":"1991","journal-title":"Int. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0055","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.149.4.1348","article-title":"Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes","volume":"149","author":"Botto","year":"1992","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0060","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.molimm.2004.06.011","article-title":"Complement: a unique innate immune sensor for danger signals","volume":"41","author":"Gasque","year":"2004","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2016.02.004_bib0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2016.02.004_bib0070","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/stem.225","article-title":"Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells","volume":"27","author":"Shinjyo","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2016.02.004_bib0075","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.devcel.2011.10.012","article-title":"Complement fragment C3a controls mutual cell attraction during collective cell migration","volume":"21","author":"Carmona-Fontaine","year":"2011","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.phrs.2016.02.004_bib0080","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2002-10-3233","article-title":"Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem\/progenitor cells, and C3a enhances their homing-related responses to SDF-1","volume":"101","author":"Reca","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0085","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.4049\/jimmunol.0803055","article-title":"C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1\/2 phosphorylation","volume":"182","author":"Schraufstatter","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0090","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/TA.0b013e3181f8aa2d","article-title":"The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro","volume":"71","author":"Ignatius","year":"2011","journal-title":"J. Trauma"},{"issue":"9","key":"10.1016\/j.phrs.2016.02.004_bib0095","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2337\/db09-0323","article-title":"The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation","volume":"58","author":"Mamane","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.02.004_bib0100","first-page":"35","article-title":"Food intake regulation by central complement system","volume":"632","author":"Ohinata","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0105","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.biocel.2009.04.005","article-title":"Complement component 5a (C5a)","volume":"41","author":"Manthey","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/pr.111.005223","article-title":"International union of basic and clinical pharmacology LXXXVII. Complement peptide C5a. C4a, and C3a receptors","volume":"65","author":"Klos","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/eji.1830240304","article-title":"C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils","volume":"24","author":"Elsner","year":"1994","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/bbrc.1998.8231","article-title":"Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS","volume":"244","author":"Matsuno","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0125","first-page":"1067","article-title":"Release of histamine from rat mast cells by the complement peptides C3a and C5a","volume":"28","author":"Johnson","year":"1975","journal-title":"Immunology"},{"issue":"September (22)","key":"10.1016\/j.phrs.2016.02.004_bib0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-5728(00)00291-5","article-title":"The C5a complement activation peptide increases IL-1beta and IL-6 release from amyloid-beta primed human monocytes: implications for Alzheimer\u2019s disease","volume":"109","author":"O\u2019Barr","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.phrs.2016.02.004_bib0135","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.4049\/jimmunol.169.10.5962","article-title":"Expression and function of C5a receptor in mouse microvascular endothelial cells","volume":"169","author":"Laudes","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0140","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/00000542-200606000-00024","article-title":"Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression","volume":"104","author":"Clark","year":"2006","journal-title":"Anesthesiology"},{"issue":"32","key":"10.1016\/j.phrs.2016.02.004_bib0145","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1523\/JNEUROSCI.2018-07.2007","article-title":"Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity","volume":"27","author":"Griffin RS1","year":"2007","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pain.2011.10.032","article-title":"The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model","volume":"153","author":"Liang","year":"2012","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.phrs.2016.02.004_bib0155","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.134.5.3325","article-title":"Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg","volume":"134","author":"Marder","year":"1985","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpain.2004.11.011","article-title":"Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization","volume":"6","author":"Twining","year":"2005","journal-title":"J. Pain"},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0165","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jlb.63.4.456","article-title":"Processing of C5a by human polymorphonuclear leukocytes","volume":"63","author":"Hetland","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2016.02.004_bib0170","first-page":"1","article-title":"Acute inflammation in peritoneal dialysis: experimental studies in rats: characterization of regulatory mechanisms","volume":"171","author":"Bazargani","year":"2005","journal-title":"Swed. Dent J. Suppl."},{"issue":"8\u20139","key":"10.1016\/j.phrs.2016.02.004_bib0175","first-page":"773","article-title":"Mechanisms of hyperpolarization of plasma membrane of macrophages and astrocytes during activation","volume":"40","author":"Gamale\u012d","year":"1998","journal-title":"Tsitologiia"},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0180","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.166.6.4154","article-title":"Neuronal expression of a functional receptor for the C5a complement activation fragment","volume":"166","author":"O\u2019Barr","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2005.03.012","article-title":"Novel biological networks modulated by complement","volume":"115","author":"Mastellos","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.phrs.2016.02.004_bib0190","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.iy.12.040194.004015","article-title":"C5A anaphylatoxin and its seven transmembrane-segment receptor","volume":"12","author":"Gerard","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors","volume":"152","author":"Monk","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.icb.7100166","article-title":"Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2","volume":"86","author":"Lee","year":"2008","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0205","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3892\/etm.2012.636","article-title":"Complement factor C5a and C5a receptor contribute to morphine tolerance and withdrawal-induced hyperalgesia in rats","volume":"4","author":"Li","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2016.02.004_bib0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0161-5890(80)90067-X","article-title":"Human C5a and C5a analogs as probes of the neutrophil C5a receptor","volume":"17","author":"Chenoweth","year":"1978","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0215","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0021-9258(18)94252-3","article-title":"Characterization of a receptor for C5a anaphylatoxin on human eosinophils","volume":"264","author":"Gerard","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0220","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V79.1.152.152","article-title":"Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes","volume":"79","author":"Werfel","year":"1992","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.phrs.2016.02.004_bib0225","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.4049\/jimmunol.155.10.4882","article-title":"Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes","volume":"155","author":"Gasque","year":"1995","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(95)00075-D","article-title":"Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia","volume":"61","author":"Lacy","year":"1995","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0006-8993(01)02003-0","article-title":"Expression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage","volume":"894","author":"Nataf","year":"2001","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2567.1999.00764.x","article-title":"Evaluation of C3a receptor expression on human leucocytes by the use of novel mono-clonal antibodies","volume":"97","author":"Zwirner","year":"1999","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0245","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: a novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.phrs.2016.02.004_bib0250","first-page":"1408","article-title":"Expression of C5aR (CD88) of synoviocytes isolated from patients with rheumatoid arthritis and osteoarthritis","volume":"116","author":"Yuan","year":"2003","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0255","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00441-012-1497-2","article-title":"Anaphylatoxin receptors and complement regulatory proteins in human articular and non-articular chondrocytes: interrelation with cytokines","volume":"350","author":"Schulze-Tanzil","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/0929867053363379","article-title":"Targeting C5a: recent advances in drug discovery","volume":"12","author":"Allegretti","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2016.02.004_bib0265","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0270","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nbt1342","article-title":"Complement-targeted therapeutics","volume":"25","author":"Ricklin","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"13\u201314","key":"10.1016\/j.phrs.2016.02.004_bib0275","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0161-5890(99)00113-3","article-title":"Complement activation and inhibition in experimental models of arthritis","volume":"36","author":"Linton","year":"1999","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2016.02.004_bib0280","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/07853890701477546","article-title":"Rheumatoid arthritis and the complement system","volume":"39","author":"Okroj","year":"2007","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1269","article-title":"The dark side of C5a in sepsis","volume":"4","author":"Ward","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2016.02.004_bib0290","doi-asserted-by":"crossref","first-page":"407324","DOI":"10.1155\/2012\/407324","article-title":"The role of complement system in septic shock","volume":"2012","author":"Charchaflieh","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0295","first-page":"364","article-title":"TP-10 (AVANT immunotherapeutics)","volume":"2","author":"Rioux","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2016.02.004_bib0300","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","article-title":"Complement and autoimmunity","volume":"56","author":"Ballanti","year":"2013","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0305","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4049\/jimmunol.148.3.928","article-title":"Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus","volume":"148","author":"Rus","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2016.02.004_bib0310","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2003.tb03138.x","article-title":"Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection","volume":"992","author":"Van Beek","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"25","key":"10.1016\/j.phrs.2016.02.004_bib0315","doi-asserted-by":"crossref","first-page":"8546","DOI":"10.1523\/JNEUROSCI.5002-13.2014","article-title":"Neurodegeneration by activation of the microglial complement-phagosome pathway","volume":"34","author":"Bodea","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0325","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1523\/JNEUROSCI.05-11-03025.1985","article-title":"The role of the polymorphonuclear leukocyte in hyperalgesia","volume":"5","author":"Levine","year":"1985","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2016.02.004_bib0330","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.bjp.0707640","article-title":"Role of complement C5a in mechanical inflammatory hypernociception: potential use of C5a receptor antagonists to control inflammatory pain","volume":"153","author":"Ting","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0335","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S0265021507003031","article-title":"The prevalence of postoperative pain in a sample of 1490 surgical inpatients","volume":"25","author":"Sommer","year":"2008","journal-title":"Eur. J. Anaesthesiol."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0340","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0304-3959(95)01441-1","article-title":"Characterization of a rat model of incisional pain","volume":"64","author":"Brennan","year":"1996","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ilar.40.3.129","article-title":"Postoperative models of nociception","volume":"40","author":"Brennan","year":"1999","journal-title":"ILAR J."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0350","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000542-200209000-00003","article-title":"Frontiers in translational research: the etiology of incisional and postoperative pain","volume":"97","author":"Brennan","year":"2002","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atc.2004.11.009","article-title":"Mechanisms of incisional pain","volume":"23","author":"Brennan","year":"2005","journal-title":"Anesthesiol. Clin. North Am."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0360","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.anes.0000267512.08619.bd","article-title":"Nerve growth factor expression after plantar incision in the rat","volume":"107","author":"Wu","year":"2007","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.phrs.2016.02.004_bib0365","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbi.2008.03.005","article-title":"Interleukin-1 signaling is required for induction and maintenance of postoperative incisional pain: genetic and pharmacological studies in mice","volume":"22","author":"Wolf","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0370","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pain.2009.06.037","article-title":"Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision","volume":"145","author":"Sahbaie","year":"2009","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0375","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1213\/ANE.0b013e3181f691eb","article-title":"The role of interleukin-1 in wound biology. Part II: in vivo and human translational studies","volume":"111","author":"Hu","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.phrs.2016.02.004_bib0380","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-8-80","article-title":"Increased local concentration of complement C5a contributes to incisional pain in mice","volume":"8","author":"Jang","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.phrs.2016.02.004_bib0385","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/j.1532-2149.2012.00240.x","article-title":"Neutrophils recruited by CXCR1\/2 signalling mediate post-incisional pain","volume":"17","author":"Carreira","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.phrs.2016.02.004_bib0390","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03019754","article-title":"Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee arthroplasty","volume":"48","author":"Andersson","year":"2001","journal-title":"Can. J. Anaesth."},{"issue":"8","key":"10.1016\/j.phrs.2016.02.004_bib0395","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.bjp.0704417","article-title":"Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist","volume":"134","author":"Strachan","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0400","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jor.21561","article-title":"C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing","volume":"30","author":"Recknagel","year":"2012","journal-title":"J. Orthop. Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.02.004_bib0405","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ajh\/hpt274","article-title":"Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension","volume":"27","author":"Zhang","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2016.02.004_bib0410","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2014.02.008","article-title":"Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice","volume":"66","author":"Li","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2016.02.004_bib0415","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/sj.bjp.0702938","article-title":"Pharmacological characterization of antagonists of the C5a receptor","volume":"128","author":"Paczkowski","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2016.02.004_bib0420","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.10449","article-title":"Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat","volume":"46","author":"Woodruff","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0425","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/jpet.105.086835","article-title":"Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease","volume":"314","author":"Woodruff","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.02.004_bib0430","article-title":"PMX53 protects spinal cord from ischemia-reperfusion injury in rats in the short term","author":"Dong","year":"2015","journal-title":"Spinal Cord"},{"key":"10.1016\/j.phrs.2016.02.004_bib0435","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nbd.2015.02.004","article-title":"A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models","volume":"76","author":"Benson","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0440","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pain.2009.11.021","article-title":"Nociceptive sensitization by complement C5a and C3a in mouse","volume":"148","author":"Jang","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.phrs.2016.02.004_bib0445","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.0409225102","article-title":"A cascade of cytokines mediates mechanical inflammatory hypernociception in mice","volume":"102","author":"Cunha","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0450","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","article-title":"Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?","volume":"112","author":"Verri","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0455","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1189\/jlb.0907654","article-title":"Crucial role of neutrophils in the development of mechanical inflammatory hypernociception","volume":"83","author":"Cunha","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"47","key":"10.1016\/j.phrs.2016.02.004_bib0460","doi-asserted-by":"crossref","first-page":"16937","DOI":"10.1073\/pnas.1417365111","article-title":"Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief","volume":"111","author":"Moriconi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0465","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1203\/01.PDR.0000150725.78971.30","article-title":"Complement C5a is a key mediator of meconium-induced neutrophil activation","volume":"57","author":"Castellheim","year":"2005","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0470","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/jpet.103.064154","article-title":"A newly identified role for superoxide in inflammatory pain","volume":"309","author":"Wang","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.02.004_bib0475","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2046-1682-7-5","article-title":"Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking","volume":"7","author":"Tamamis","year":"2014","journal-title":"BMC Biophys."},{"issue":"5","key":"10.1016\/j.phrs.2016.02.004_bib0480","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.2040-1124.2010.00046.x","article-title":"Relationship between urinary sodium excretion and pioglitazone-induced edema","volume":"1","author":"Nakamura","year":"2010","journal-title":"J. Diabetes Investig."},{"issue":"22","key":"10.1016\/j.phrs.2016.02.004_bib0485","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1074\/jbc.M115.642736","article-title":"Neutrophil elastase activates protease-activated receptor-2 (PAR2) and transient receptor potential vanilloid 4 (TRPV4) to cause inflammation and pain","volume":"290","author":"Zhao","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.02.004_bib0490","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2015.05.007","article-title":"Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-\u03baB","volume":"237","author":"Ruiz-Miyazawa","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0495","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1529-0131(199802)41:2<233::AID-ART7>3.0.CO;2-V","article-title":"Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis","volume":"41","author":"Kiener","year":"1998","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0500","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9440(10)65295-9","article-title":"C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells","volume":"154","author":"Fayyazi","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0505","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface","volume":"14","author":"Grace","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0510","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2014.03.001","article-title":"Martinov T2. Mast cells: versatile gatekeepers of pain","volume":"63","author":"Chatterjea","year":"2015","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0515","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanisms of disease: neuropathic pain-a clinical perspective","volume":"2","author":"Baron","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0520","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nm.2231","article-title":"Central mechanisms of pathological pain","volume":"16","author":"Kuner","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/187152409787601932","article-title":"Mechanisms and treatment of neuropathic pain","volume":"9","author":"Vranken","year":"2009","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0530","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tins.2004.12.002","article-title":"Neuropathic pain and spinal microglia: a big problem from molecules in small glia","volume":"28","author":"Tsuda","year":"2005","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0535","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0540","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S1740925X08000100","article-title":"Do glial cells control pain?","volume":"3","author":"Suter","year":"2007","journal-title":"Neuron Glia Biol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2016.02.004_bib0545","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","article-title":"The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines","volume":"229","author":"Austin","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2016.02.004_bib0550","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-3-540-79090-7_12","article-title":"Cytokine and chemokine regulation of sensory neuron function","volume":"194","author":"Miller","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"17","key":"10.1016\/j.phrs.2016.02.004_bib0555","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1523\/JNEUROSCI.18-17-06713.1998","article-title":"Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration","volume":"18","author":"Dailey","year":"1998","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0560","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0304-3940(95)12115-K","article-title":"Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats","volume":"200","author":"Jung","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.phrs.2016.02.004_bib0565","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1111\/j.1460-9568.2007.05971.x","article-title":"Complement activation contributes to leukocyte recruitment and neuropathic pain following peripheral nerve injury in rats","volume":"26","author":"Li","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"July (1\u20132)","key":"10.1016\/j.phrs.2016.02.004_bib0570","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.04.008","article-title":"Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats","volume":"110","author":"Twining","year":"2004","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.phrs.2016.02.004_bib0575","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0306-4522(00)00396-1","article-title":"Hyperalgesia due to nerve injury: role of neutrophils","volume":"101","author":"Perkins","year":"2000","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.phrs.2016.02.004_bib0580","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0166-2236(00)01854-3","article-title":"Glial activation: a driving force for pathological pain","volume":"24","author":"Watkins","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2016.02.004_bib0585","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.51.1.29","article-title":"The pain of being sick: implications of immune-to-brain communication for understanding pain","volume":"51","author":"Watkins","year":"2000","journal-title":"Annu. Rev. Psychol."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0590","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1152\/physrev.00011.2002","article-title":"Beyond neurons: evidence that immune and glial cells contribute to pathological pain states","volume":"82","author":"Watkins","year":"2002","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2016.02.004_bib0595","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nrd1251","article-title":"A novel drug discovery target for clinical pain","volume":"2","author":"Watkins","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.phrs.2016.02.004_bib0600","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2796.2004.01443.x","article-title":"Immune regulation of central nervous system functions: from sickness responses to pathological pain","volume":"257","author":"Watkins","year":"2005","journal-title":"J. Intern. Med."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2016.02.004_bib0605","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuint.2003.09.009","article-title":"Glial activation and pathological pain","volume":"45","author":"Wieseler-Frank","year":"2004","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0610","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000087655","article-title":"Central proinflammatory cytokines and pain enhancement","volume":"14","author":"Wieseler-Frank","year":"2005","journal-title":"Neurosignals"},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0615","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nm.2234","article-title":"Interactions between the immune and nervous systems in pain","volume":"16","author":"Ren","year":"2010","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.phrs.2016.02.004_bib0620","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.phrs.2016.02.004_bib0625","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.139.7.2361","article-title":"Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation","volume":"139","author":"L\u00e9vi-Strauss","year":"1987","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0630","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1385\/IR:24:1:79","article-title":"The complement system in central nervous system diseases","volume":"24","author":"Rus","year":"2001","journal-title":"Immunol. Res."},{"key":"10.1016\/j.phrs.2016.02.004_bib0635","article-title":"The membrane attack complex as an inflammatory trigger","author":"Morgan","year":"2015","journal-title":"Immunobiology"},{"issue":"16","key":"10.1016\/j.phrs.2016.02.004_bib0640","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury","volume":"35","author":"Brennan","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0645","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pain.2007.11.005","article-title":"Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain","volume":"137","author":"Levin","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.02.004_bib0650","doi-asserted-by":"crossref","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","author":"Morgan","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.phrs.2016.02.004_bib0655","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrd3011","article-title":"Therapeutic potential of complement modulation","volume":"9","author":"Wagner","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2016.02.004_bib0660","first-page":"1017","article-title":"Eculizumab (Alexion)","volume":"3","author":"Kaplan","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.phrs.2016.02.004_bib0665","unstructured":"FDA. FDA approves Soliris for rare pediatric blood disorder: Orphan drug receives second approval for rare disease. FDA, 23 September 2011, retrieved 25 June (2015)."},{"key":"10.1016\/j.phrs.2016.02.004_bib0670","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.02.004_bib0675","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajh.2830160110","article-title":"Intestinal infarction caused by paroxysmal nocturnal hemoglobinuria","volume":"16","author":"Doukas","year":"1984","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.phrs.2016.02.004_bib0680","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracelular plasma hemoglobin","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.phrs.2016.02.004_bib0685","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1445-5994.2010.02315.x","article-title":"Durable resolution of recurrent microvascular small bowel ischaemia and severe abdominal pain by eculizumabin paroxysmal nocturnal haemoglobinuria","volume":"40","author":"Grigg","year":"2010","journal-title":"Intern. Med. J."},{"issue":"9","key":"10.1016\/j.phrs.2016.02.004_bib0690","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/pbc.25068","article-title":"Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria","volume":"61","author":"Reiss","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2016.02.004_bib0695","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1182\/blood-2003-03-0703","article-title":"Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis","volume":"102","author":"Sprong","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.02.004_bib0700","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1021\/jm9806594","article-title":"Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a","volume":"42","author":"Finch","year":"1999","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2016.02.004_bib0705","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/mol.65.4.868","article-title":"Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity","volume":"65","author":"March","year":"2004","journal-title":"Mol. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:13:57Z","timestamp":1718360037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":141,"alternative-id":["S1043661816000414"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.02.004","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C5a and pain development: An old molecule, a new target","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}